Talazoparib Formulation Bridging in Cancer Patients-Challenges and the Critical Role of Model-Informed Drug Development in Approval Despite Failed Bioequivalence. - Wang D; Guo CC; Gao X; Wang Y; Yu Y; Plotka A; Elmeliegy M; Shi H; Johnson S; DeAnnuntis L; Hoffman J (CPT: pharmacometrics & systems pharmacology, 2026)